A written piece on BioNews Texas spoke about the matter, saying that the RIP1 protein could play into cancer research in general. It can help to control of the growth of a number of different cells in the brain you could think of, with glioblastomas being seen amongst the group. The article said that there was a study done at the UT Southwestern Medical Center and it appears as though quite a bit of strong information was uncovered. It's the kind of information that deserves the attention of organizations the likes of Voices against Brain Cancer.
The RIP1 protein, from what I have picked up on, operates as a cellular switch for tumors in general. More specifically, it is able to maintain to take control of the survival rates of tumor cells, which is done when the protein in question comes into contact with EGFRvIII, which is a receptor. RIP1 and EGFRvIII can come together in order to create NFB as well. What this does is allow the progression of growths within the brain to be regulated; this is pertinent information, to say the least.
It seems like, thanks to this type of information, there could be a solid foundation for finding cures for glioblastomas. For those who do not know, these particular tumors are among the most common - not to mention the most aggressive - within the human body. It's been said that about 30% of tumors found in the brain fall under this category, so it is apparent that they make up for a great percentage. It should be obvious why these particular growths are the focus of many different therapies.
I believe that any kind of information you could think of when it comes to cancer research is going to be immensely helpful in the future. Being able to pick up on smaller details could potentially make all of the difference when it comes to formulating therapies, from the way that I see it. After all, brain cancer is one of the most intricate types of studies out there. It's also one of the greatest endeavors to become involved in and information is very much required.
About the Author:
No comments:
Post a Comment